A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Songorine | Songorine. Group: Biochemicals. CAS No. 509-24-0. Pack Sizes: 5mg. US Biological Life Sciences. |  Worldwide |
| Sonidegib | Sonidegib (Erismodegib) is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Erismodegib; LDE225; NVP-LDE225. CAS No. 956697-53-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg; 1 g. Product ID: HY-16582A. |  |
| Sonidegib diphosphate | Sonidegib diphosphate (Erismodegib diphosphate) is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Erismodegib diphosphate; LDE225 diphosphate; NVP-LDE225 diphosphate. CAS No. 1218778-77-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16582. | |
| Sonidegib (NVP-LDE225, Erismodegib) | Sonidegib is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human) in cell-free assays, respectively. Phase 3. Group: Inhibitors. Alternative Names: NVP-LDE225, Erismodegib. CAS No. 956697-53-3. Pack Sizes: 5mg. Product ID: S2151. Formula: C26H26F3N3O3. Smiles: CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F. Storage Conditions: 2 years -80 in solvent. |  United States; Europe |
| Sonlicromanol | Sonlicromanol (KH176) is an orally active reactive oxygen species (ROS) modulator for the study in mitochondrial disease[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: KH176. CAS No. 1541170-75-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-121577. | |
| Sonnerphenolic B | Sonnerphenolic B, a natural compound, has been found to showcase great potential in the realm of cancer and inflammation therapy owing to its proficient anti-tumor and anti-inflammatory activities. Clinical trials have furnished evidence that this compound is capable of stalling the proliferation of both breast cancer cells and human colon cancer cells. Besides, the compound can effectively alleviate inflammation in activated macrophages. Ultimately, Sonnerphenolic B demonstrates promise as a natural therapeutic agent for the management of cancer and inflammation. Synonyms: (+)-Sonnerphenolic B. Grade: 97.5%. CAS No. 1627516-10-2. Molecular formula: C18H18O3. Mole weight: 282.34. |  |
| Sonolisib | Sonolisib, also known as PX-866, is a small-molecule wortmannin analogue inhibitor of the alpha, gamma, and delta isoforms of phosphoinositide 3-kinase (PI3K) with potential antineoplastic activity. PI3K inhibitor PX-866 inhibits the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) and activation of the PI3K/Akt signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents. Uses: Potential anti-cancer agent. Synonyms: PX-866; PX866; PX 866. Grade: >98%. CAS No. 502632-66-8. Molecular formula: C29H35NO8. Mole weight: 525.59. | |
| Sonolisib | Sonolisib (PX-866), an improved Wortmannin analogue, is an oral, irreversible, and pan-isoform inhibitor of PI3K (IC50=0.1 nM (p110α), 1.0 nM (p120γ), 2.9 nM (p110δ)). Antitumor activity[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PX-866. CAS No. 502632-66-8. Pack Sizes: 5 mg; 10 mg. Product ID: HY-N6775. | |
| Sonrotoclax | Sonrotoclax is a potent, orally active Bcl2 inhibitor. Sonrotoclax has effective cell killing effect against a variety of lymphoma and leukemia cell lines[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BGB 11417. CAS No. 2383086-06-2. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148026. | |
| Sontigidomide | Sontigidomide (Compound 5) is an antineoplastic compound. Sontigidomide inhibits MOLM-13 cell proliferation more than 80% at 1 μM (3 days)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2560577-69-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-156641. | |
| Sontuzumab | Sontuzumab (AS1402) is a humanizedised IgG1κ MUC1 specific monoclonal antibody. Sontuzumab binds the extracellular MUC1 peptide sequence PDTR with a Kd of ~1 nM. Sontuzumab can be used for the research of breast cancer[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AS1402; huHMFG-1; Epitumomab. CAS No. 372075-37-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99591. | |
| Soot Carbon Black Nanopowder | Soot Carbon Black Nanopowder. CAS No. 7440-44-0. Molecular formula: C. Mole weight: 12.011 g/mol. Purity: 98.9%. |  |
| Sootepin D | Sootepin D is a natural compound isolated from the fruits of Gardenia jasminoides Ellis. Synonyms: Sootepin D; 1154518-97-4; methyl 3-[(1S,4R,5R,8S,9S,12R,13R)-12-(3-hydroxyprop-1-en-2-yl)-4,8-dimethyl-5-[(E,2R)-6-methyl-7-oxohept-5-en-2-yl]-13-tetracyclo[7.5.0.01,13.04,8]tetradecanyl]propanoate; CHEMBL552070; ZINC96023730. Grade: 93.0%. CAS No. 1154518-97-4. Molecular formula: C31H48O4. Mole weight: 484.721. | |
| SOP1812 | SOP1812 (QN-302) is a naphthalene diimide (ND) derivative with anti-tumor activity. SOP1812 binds to quadruplex arrangements (G4s), and down-regulates several cancer gene pathways. SOP1812 shows great affinity to hTERT G4 and HuTel21 G4 with KD values of 4.9 and 28.4 nM, respectively. SOP1812 can be used for the research of cancer[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: QN-302. CAS No. 2546091-70-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-148012. | |
| SOPC | SOPC (PC (18:0/18:1)) is a phosphatidylcholine lipid, which is an unsaturated phospholipid containing a cis double bond. When SOPC binds to Imatinib (HY-15463), Imatinib easily penetrates into its unsaturated liposome bilayer structure, and SOPC forms ordered, larger parallel stripe domains[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PC(18:0/18:1); 2-Oleoyl-1-stearoyl-sn-glycero-3-phosphocholine. CAS No. 56421-10-4. Pack Sizes: 10 mg; 25 mg; 50 mg. Product ID: HY-W440982. | |
| Sophocarpine | Sophocarpine. Group: Biochemicals. Alternative Names: 13,14-Didehydromatridin-15-one, 9CI. Grades: Plant Grade. CAS No. 6483-15-4,145572-44-7. Pack Sizes: 20mg. Molecular Formula: C15H22N2O, Molecular Weight: 246.348. US Biological Life Sciences. | Worldwide |
| Sophocarpine | Sophocarpine, a major ingredient of Sophora alopecuroides, has a wide range of pharmacological effects. Sophocarpine significantly inhibits the growth of gastric cancer (GC) cells through multiple mechanisms such as induction of autophagy, activation of cell apoptosis and down-regulation of cell survival PI3K/AKT signaling pathway. Uses: Anti-tumor; anti-cancer; antiarrhythmic. Synonyms: AS 604850; AS604850; AS-604850; 13,14-Didehydromatridin-15-one; (7aS,13aR,13bR,13cS)-2,3,6,7,7a,8,13,13a,13b,13c-decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one. Grade: >98%. CAS No. 6483-15-4. Molecular formula: C15H22N2O. Mole weight: 246.35. | |
| Sophoflavescenol | Sophoflavescenol. Group: Biochemicals. Grades: Plant Grade. CAS No. 216450-65-6. Pack Sizes: 5mg. Molecular Formula: C21H20O6, Molecular Weight: 368.38. US Biological Life Sciences. | Worldwide |
| Sophoflavescenol | Sophoflavescenol is a prenylated flavonol, which shows great inhibitory activity with IC50 of 0.013 μM against Phosphodiesterase 5 (PDE5), and also inhibits RLAR, HRAR, AGE, BACE1, AChE and BChE with IC50s of 0.30 μM, 0.17 μM, 17.89 μg/mL, 10.98 μM, 8.37 μM and 8.21 μM, respectively. Uses: Scientific research. Category: Signaling pathways. CAS No. 216450-65-6. Pack Sizes: 1 mg; 5 mg. Product ID: HY-N2284. | |
| Sophorabioside | Sophorabioside. Group: Biochemicals. CAS No. 2945-88-2. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Sophoraflavanone G | Sophoraflavanone G (Kushenol F) is iaolated from Sophora flavescens and shows anti-tumor and anti-inflammatory properties.? Sophoraflavanone G (Kushenol F) induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Kushenol F. CAS No. 97938-30-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 20 mg; 50 mg; 100 mg. Product ID: HY-N1231. | |
| Sophoraflavanone G | Sophoraflavanone G is isolated from the roots of Sophora flavescens Ait. It is a novel small-molecule inhibitor of STAT. Uses: Anti-inflammatory effect; antimicrobial activity. Synonyms: (S)-2,3-Dihydro-5,7-dihydroxy-2-(2,4-dihydroxyphenyl)-6-[(R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-benzopyran-4-one; (2S)-5,7-Dihydroxy-2,3-dihydro-2α-(2,4-dihydroxyphenyl)-8-[(R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-4H-1-benzopyran-4-one. Grade: 98.5%. CAS No. 97938-30-2. Molecular formula: C25H28O6. Mole weight: 424.5. | |
| Sophora Flavescens P.E. 5:1 | Sophora Flavescens P.E. 5:1. |  CA, FL & NJ |
| Sophoraflavonoloside | Sophoraflavonoloside. Group: Biochemicals. CAS No. 19895-95-5. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Sophora Japonica Extract Rutin 95%UV | Sophora Japonica Extract Rutin 95%UV. | CA, FL & NJ |
| Sophora Root Extract | Sophora root extract is prepared from the sophora flavescens, a species of plant in the genus sophora. Matrine is the major alkaloid component found in sophora root extract. Sophora root extract is commonly used for the treatment of viral hepatitis, enteritis, cancer, viral myocarditis, gastrointestinal hemorrhage and skin diseases. Group: Others. Mole weight: 248.37. Sophora Root Extract; Sophora Flavescens Alt. Cat No: EXTC-019. |  |
| Sophoricoside | Sophoricoside. Group: Biochemicals. Alternative Names: Genistein 4?-glucoside. Grades: Plant Grade. CAS No. 152-95-4. Pack Sizes: 20mg. Molecular Formula: C21H20O10, Molecular Weight: 432.377999999999. US Biological Life Sciences. | Worldwide |
| Sophoricoside | Source from the pod of a pagoda tree. Sophoricoside as a potential molecule is for use in the treatment of allergic inflammation diseases, also an effective regulator of lipogenesis and glucose consumption and may find utility in the treatment of obesity and type 2 diabetes, exposuring reduced the number of implanted embryos in a dose-dependent manner and failed the embryo implantation through altering the morphology of uterine and compromising the endometrial receptivity. Uses: Anti-inflammatory, inhibiting the immune, blood sugar. Synonyms: 3-[4-(b-D-Glucopyranosyloxy)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one. Grade: >98%. CAS No. 152-95-4. Molecular formula: C21H20O10. Mole weight: 432.38. | |
| Sophoridine | Sophoridine. Group: Biochemicals. Grades: Plant Grade. CAS No. 6882-68-4. Pack Sizes: 20mg. Molecular Formula: C15H24N2O, Molecular Weight: 248.36. US Biological Life Sciences. | Worldwide |
| Sophorolipid | Sophorolipid is a glycolipid biosurfactant, one of the well-known high-performance biosurfactants, which is mainly produced by non-pathogenic yeasts. Sophorolipid has an excellent environmental profile in terms of toxicity, biodegradability and surface activity better than synthetic analogs. Applications: Sophorolipid has great potential applications in the food and cosmetic industries as natural emulsifiers, wetting agents, biopreservatives due to its potent antimicrobial activity and good skin compatibility. sophorolipid has been explored for various applications in the pharmaceutical industry as a drug delivery vehicle and therapeutic agent. Category: Natural extract. Synonyms: (E)-17-[(2R,3R,4S,5S,6R)-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxyoctadec-9-enoic acid. Product ID: PIPE-0294. Molecular formula: C34H58O15. Mole weight: 706.8. InChIKey: ZTOKUMPYMPKCFX-CZNUEWPDSA-N. |  |
| Soquelitinib | Soquelitinib (CPI-818) is an orally active and highly selective covalent interleukin-2-inducible kinase (ITK) inhibitor. Soquelitinib is active in six different models of T cell-mediated inflammatory and immune disease, including acute and chronic asthma, pulmonary fibrosis, systemic sclerosis (scleroderma), psoriasis, and acute graft versus host disease with Th2 cytokine product inhibition. Soquelitinib increases tumor infiltration of normal CD8+ cells that possess enhanced T effector function[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CPI-818. CAS No. 2226636-04-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-150298. | |
| Sorafenib | Sorafenib (Bay 43-9006) is a multikinase inhibitor that targets Raf-1, B-Raf, VEGFR2, VEGFR3, VEGFR4, PDGFRβ, FLT3, c-Kit, and others (IC50=6/22/90/15/20/20/57/58 nM) with oral activity. It exhibits antitumor properties and can induce autophagy, apoptosis, and agonistic iron death. Category: Active pharmaceutical ingredients. CAS No. 284461-73-0. Product ID: API284461730. Molecular formula: C21H16ClF3N4O3. Mole weight: 464.82. | |
| Sorafenib | Sorafenib (Bay 43-9006) is a potent oral active multikinase inhibitor. Sorafenib blocks autophosphorylation and activity of receptor tyrosine kinases (VEGFR-2, VEGFR-3) and RAF family kinases, thereby suppressing the RAF/MEK/ERK and PI3K/Akt pathways, inhibiting STAT3 phosphorylation, and selectively inhibiting the MAPK pathway in cancer cells. Sorafenib induces cell cycle arrest, autophagy, apoptosis, and PARP cleavage, reduces Bcl-2, Bcl-XL, cyclin D1 levels, and activates Bak and Bax. Sorafenib inhibits tumor growth and metastasis in mouse and rat models. Sorafenib can be used for cancer research, such as colon, breast, non-small-cell lung cancer (NSCLC), ovarian, pancreatic, melanoma, colorectal and hepatocellular carcinoma[1][2][3][4][5][6]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Bay 43-9006. CAS No. 284461-73-0. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg; 500 mg; 1 g. Product ID: HY-10201. | |
| Sorafenib | Sorafenib is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively. Synonyms: BAY 43-9006. Grade: >98%. CAS No. 284461-73-0. Molecular formula: C21H16ClF3N4O3. Mole weight: 464.82. | |
| Sorafenib | Sorafenib Inhibitor. Uses: Scientific use. Product Category: T0093L. CAS No. 284461-73-0. |  |
| Sorafenib-13C,d3 | Sorafenib-13C,d3 is the 13C- and deuterium labeled Sorafenib. Sorafenib (Bay 43-9006) is a potent and orally active Raf inhibitor with IC50s of 6 nM and 20 nM for Raf-1 and B-Raf, respectively. Sorafenib is a multikinase inhibitor with IC50s of 90 nM, 15 nM, 20 nM, 57 nM and 58 nM for VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit, respectively. Sorafenib induces autophagy and apoptosis. Sorafenib has anti-tumor activity. Sorafenib is a ferroptosis activator[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Bay 43-9006-13C,d3. CAS No. 1210608-86-8. Pack Sizes: 100 μg; 1 mg; 5 mg; 10 mg. Product ID: HY-10201S2. | |
| Sorafenib (BAY 43-9006) | Sorafenib is a multikinase inhibitor of Raf-1 and B-Raf with IC50 of 6 nM and 22 nM in cell-free assays, respectively. Sorafenib inhibits VEGFR-2, VEGFR-3, PDGFR-β, Flt-3 and c-KIT with IC50 of 90 nM, 20 nM, 57 nM, 59 nM and 68 nM, respectively. Sorafenib induces autophagy and apoptosis and activates ferroptosis with anti-tumor activity. Group: Inhibitors. Alternative Names: NSC-724772,BAY 43-9006. CAS No. 284461-73-0. Pack Sizes: 20mg. Product ID: S7397. Formula: C21H16ClF3N4O3. Smiles: CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F. Storage Conditions: 2 years -80 in solvent. | United States; Europe |
| Sorafenib-d3 | Sorafenib-d3 (Donafenib), a deuterated compound of Sorafenib, is the first deuterium-generation tumor suppressor small molecule. Sorafenib is a multikinase inhibitor IC50s of 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Donafenib; Bay 43-9006-d3. CAS No. 1130115-44-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg. Product ID: HY-10201S. | |
| Sorafenib-[d3] | Sorafenib-[d3] is the labelled analogue of Sorafenib, which is a potent RAF kinase inhibitor and an antineoplastic. Synonyms: Sorafenib-d3; Sorafenib-(methyl-d3); 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-(methyl-d3)-2-pyridinecarboxamide. Grade: ≥98%; ≥99% atom D. CAS No. 1130115-44-4. Molecular formula: C21H13D3ClF3N4O3. Mole weight: 467.84. | |
| Sorafenib-d4 | Sorafenib D4 is the deuterium labeled Sorafenib. Sorafenib is an inhibitor of multikinase (Raf-1, B-Raf, and VEGFR-3 IC50s of 6 nM, 20 nM, and 22 nM, respectively). Category: Active pharmaceutical ingredients. CAS No. 1207560-07-3. Product ID: API1207560073. Molecular formula: C21H16ClF3N4O3. Mole weight: 468.85. | |
| Sorafenib-[d4] | Sorafenib-[d4] is the labelled analogue of Sorafenib. Sorafenib is a small inhibitor of several tyrosine protein kinases, such as VEGFR, PDGFR and Raf family kinases, for the treatment of primary kidney cancer, advanced primary liver cancer and radioactive iodine resistant advanced thyroid carcinoma. Synonyms: Sorafenib-d4. Grade: 95% by HPLC; 95% atom D. CAS No. 1207560-07-3. Molecular formula: C21H12D4ClF3N4O3. Mole weight: 468.85. | |
| Sorafenib Impurity 10 | Sorafenib Impurity 10. Uses: For analytical and research use. CAS No. 284461-82-1. Molecular formula: C22H18ClF3N4O3. Mole weight: 478.86. Catalog: APB284461821. |  |
| Sorafenib Impurity 11 | Sorafenib Impurity 11. Uses: For analytical and research use. CAS No. 1290546-48-3. Molecular formula: C21H16ClF3N4O3. Mole weight: 464.83. Catalog: APB1290546483. | |
| Sorafenib Impurity 11073 | Sorafenib Impurity 11073. Uses: For analytical and research use. CAS No. 2090542-70-2. Molecular formula: C7H7FN2O3. Mole weight: 186.14. Catalog: APB2090542702. | |
| Sorafenib Impurity 13 | Sorafenib Impurity 13. Uses: For analytical and research use. CAS No. 583840-04-4. Molecular formula: C20H14ClF3N4O4. Mole weight: 466.8. Catalog: APB583840044. | |
| Sorafenib Impurity 14 | Sorafenib Impurity 14. Uses: For analytical and research use. CAS No. 2206827-14-5. Molecular formula: C17H19N3O4. Mole weight: 329.36. Catalog: APB2206827145. | |
| Sorafenib Impurity 15 | Sorafenib Impurity 15. Uses: For analytical and research use. CAS No. 871555-75-8. Molecular formula: C14H9ClF3NO2. Mole weight: 315.68. Catalog: APB871555758. | |
| Sorafenib Impurity 16 | Sorafenib Impurity 16. Uses: For analytical and research use. CAS No. 2206827-12-3. Molecular formula: C16H17N3O4. Mole weight: 315.33. Catalog: APB2206827123. | |
| Sorafenib Impurity 17 | Sorafenib Impurity 17. Uses: For analytical and research use. CAS No. 53750-66-6. Molecular formula: C6H3Cl2NO. Mole weight: 176. Catalog: APB53750666. | |
| Sorafenib Impurity 2 | Sorafenib Impurity 2. Uses: For analytical and research use. CAS No. 114780-06-2. Molecular formula: C8H9ClN2O. Mole weight: 184.62. Catalog: APB114780062. | |
| Sorafenib Impurity 22 | Sorafenib Impurity 22. Uses: For analytical and research use. CAS No. 777-37-7. Molecular formula: C7H3ClF3NO2. Mole weight: 225.55. Catalog: APB777377. | |
| Sorafenib Impurity 24 | Sorafenib Impurity 24. Uses: For analytical and research use. CAS No. 39974-35-1. Molecular formula: C7H3ClF3NO2. Mole weight: 225.55. Catalog: APB39974351. | |
| Sorafenib Impurity 27 | Sorafenib Impurity 27. Uses: For analytical and research use. CAS No. 583840-03-3. Molecular formula: C21H16ClF3N4O4. Mole weight: 480.83. Catalog: APB583840033. | |
| Sorafenib Impurity 31 | Sorafenib Impurity 31. Uses: For analytical and research use. CAS No. 62476-58-8. Molecular formula: C7H5ClF3N. Mole weight: 195.57. Catalog: APB62476588. | |
| Sorafenib Impurity 34 | Sorafenib Impurity 34. Uses: For analytical and research use. CAS No. 121-50-6. Molecular formula: C7H5ClF3N. Mole weight: 195.57. Catalog: APB121506. | |
| Sorafenib Impurity 43 | Sorafenib Impurity 43. Uses: For analytical and research use. CAS No. 757251-59-5. Molecular formula: C13H12N2O3. Mole weight: 244.25. Catalog: APB757251595. | |
| Sorafenib Impurity 53 | Sorafenib Impurity 53. Uses: For analytical and research use. CAS No. 1209459-88-0. Molecular formula: C7H7BrN2O. Mole weight: 215.05. Catalog: APB1209459880. | |
| Sorafenib Impurity 5 (Regorafenib Impurity 5) | Sorafenib Impurity 5 (Regorafenib Impurity 5). Uses: For analytical and research use. CAS No. 320-51-4. Molecular formula: C7H5ClF3N. Mole weight: 195.57. Catalog: APB320514. | |
| Sorafenib Impurity 6 | Sorafenib Impurity 6. Uses: For analytical and research use. CAS No. 2204442-52-2. Molecular formula: C27H23N5O6. Mole weight: 513.51. Catalog: APB2204442522. | |
| Sorafenib Impurity 73 | Sorafenib Impurity 73. Uses: For analytical and research use. CAS No. 862875-16-9. Molecular formula: C21H17F3N4O4. Mole weight: 446.39. Catalog: APB862875169. | |
| Sorafenib Impurity 84 | Sorafenib Impurity 84. Uses: For analytical and research use. CAS No. 1403469-80-6. Molecular formula: C7H6Cl2N2O. Mole weight: 205.04. Catalog: APB1403469806. | |
| Sorafenib Impurity 85 | Sorafenib Impurity 85. Uses: For analytical and research use. CAS No. 1021077-12-2. Molecular formula: C7H6Cl2N2O. Mole weight: 205.04. Catalog: APB1021077122. | |
| Sorafenib Impurity 86 | Sorafenib Impurity 86. Uses: For analytical and research use. CAS No. 1793080-72-4. Molecular formula: C21H17F4N2O7P. Mole weight: 516.34. Catalog: APB1793080724. | |
| Sorafenib Impurity 87 | Sorafenib Impurity 87. Uses: For analytical and research use. CAS No. 24484-93-3. Molecular formula: C7H6ClNO2. Mole weight: 171.58. Catalog: APB24484933. | |
| Sorafenib Impurity 88 | Sorafenib Impurity 88. Uses: For analytical and research use. CAS No. 2004659-85-0. Molecular formula: C13H12N2O2. Mole weight: 228.25. Catalog: APB2004659850. | |
| Sorafenib Impurity G | Sorafenib Impurity G. Uses: For analytical and research use. Alternative Names: ethyl (4-chloro-3-(trifluoromethyl)phenyl)carbamate. CAS No. 18585-06-3. Molecular formula: C10H9ClF3NO2. Mole weight: 267.63. Catalog: APB18585063. | |
| Sorafenib Impurity INT-1-B | Sorafenib Impurity INT-1-B. Uses: For analytical and research use. CAS No. 220000-87-3. Molecular formula: C7H7ClN2O. Mole weight: 170.6. Catalog: APB220000873. | |
| Sorafenib Impurity INT-1-F | Sorafenib Impurity INT-1-F. Uses: For analytical and research use. CAS No. 1065074-98-7. Molecular formula: C8H11N3O. Mole weight: 165.2. Catalog: APB1065074987. | |
| Sorafenib Impurity INT-1-N | Sorafenib Impurity INT-1-N. Uses: For analytical and research use. CAS No. 1863331-80-9. Molecular formula: C9H13N3O. Mole weight: 179.22. Catalog: APB1863331809. | |
| Sorafenib Impurity INT-1-O | Sorafenib Impurity INT-1-O. Uses: For analytical and research use. Molecular formula: C9H14N4O. Mole weight: 194.24. Catalog: APB09538. | |
Our database is helping our users find suppliers everyday.
